Kolacheva A A, Ugrumov M V
Koltzov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, 119334, Russia.
Dokl Biochem Biophys. 2018 Mar;479(1):83-86. doi: 10.1134/S1607672918020096. Epub 2018 May 19.
Using an experimental Parkinson's disease model (symptoms develop in mice after the injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), we studied the characteristics of the synthesis of dopamine as a possible compensatory mechanism aimed at maintaining the dopamine level in the dopaminergic neurons that survived in this pathology. We found no correlation between the content and activity of tyrosine hydroxylase in the nigrostriatal system. The enzyme activity and the dopamine content showed unidirectional changes in the substantia nigra, but not in the striatum, which is apparently due to triggering other compensatory mechanisms.
利用一种实验性帕金森病模型(小鼠在注射1-甲基-4-苯基-1,2,3,6-四氢吡啶后出现症状),我们研究了多巴胺合成的特征,其作为一种可能的补偿机制,旨在维持在这种病理状态下存活的多巴胺能神经元中的多巴胺水平。我们发现黑质纹状体系统中酪氨酸羟化酶的含量与活性之间没有相关性。该酶活性和多巴胺含量在黑质中呈现单向变化,但在纹状体中并非如此,这显然是由于触发了其他补偿机制。